MedPath

上海银诺医药技术有限公司

Ownership
-
Established
2015-03-06
Employees
-
Market Cap
-
Website
www.innogenpharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

4

NMPA:4

Drug Approvals

Efsubaglutide Alfa Injection

Product Name
怡诺轻
Approval Number
国药准字S20250008
Approval Date
Jan 24, 2025
NMPA

Efsubaglutide Alfa Injection

Product Name
怡诺轻
Approval Number
国药准字S20250009
Approval Date
Jan 24, 2025
NMPA

Efsubaglutide Alfa Injection

Product Name
怡诺轻
Approval Number
国药准字S20250007
Approval Date
Jan 24, 2025
NMPA

Efsubaglutide Alfa Injection

Product Name
怡诺轻
Approval Number
国药准字S20250010
Approval Date
Jan 24, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.